How Meadow Is Reimagining Menopause Care for 1.3 Billion Women

The Most Undertreated Transition in Medicine

Every woman who lives long enough will experience menopause. That's not a niche health concern — it's a universal biological transition affecting roughly 1.3 billion women worldwide by 2030. Yet somehow, menopause remains one of the most undertreated, under-researched, and poorly understood chapters in all of medicine.

The average woman sees three different doctors before receiving adequate menopause care. Many are told their symptoms are stress, anxiety, or simply "a part of getting older." Hot flashes, sleep disruption, cognitive fog, joint pain, mood changes, and sexual health shifts are routinely dismissed or undertreated — not because solutions don't exist, but because the medical system never built proper infrastructure around this transition.

That's the problem Meadow was built to solve.

What Meadow Does

Meadow is a clinical platform purpose-designed for menopause — not a general telehealth service that treats it as an afterthought, but a dedicated care environment built from the ground up for this specific transition. Every provider on the platform is a board-certified menopause specialist. Every treatment protocol reflects current, evidence-based guidance rather than the outdated fear-based approaches that still dominate primary care.

The tagline says it plainly: Menopause care designed by women who've been there. This isn't marketing language. It reflects a founding philosophy that the people building this care infrastructure should understand menopause not just clinically, but experientially.

The Clinical Experience

When a woman joins Meadow, she doesn't get routed to a general practitioner who sees menopause patients twice a month. She connects with a specialist who sees this every day — who understands the nuance between perimenopause and menopause, who can read hormone panels in context, and who stays current on evolving guidance from bodies like the Menopause Society.

Care plans are genuinely personalized. Meadow considers the complete health picture: hormonal therapy options for women who are appropriate candidates, non-hormonal alternatives for those who prefer or require them, and lifestyle interventions that actually move the needle on quality of life. Whether a woman is experiencing her first hot flash at 43 or navigating bone density concerns at 58, the platform meets her where she is.

The Community Layer

Clinical care is only half the equation. Menopause is isolating in a way that few health transitions are. It doesn't come with the social scaffolding of pregnancy or the shared experience of adolescence. Friends don't talk about it. Partners don't understand it. Many women feel like they're navigating something enormous entirely alone.

Meadow's community layer exists to change that — bringing together women at every stage of the transition to share experiences, ask questions openly, and reframe what this chapter can look like. The goal isn't just better symptom management. It's a fundamental shift in how women experience and relate to this phase of their health.

Who Meadow Is For

Meadow's core audience is women in perimenopause and menopause — typically between 40 and 65 — but the platform serves a broader set of needs than age alone defines.

• The newly symptomatic: Women in their early-to-mid 40s experiencing symptoms they don't yet recognize as perimenopause — irregular cycles, sleep disruption, mood shifts — who are getting dismissed by generalists.
• The frustrated navigator: Women who've already seen multiple providers, received conflicting advice, and are exhausted by the process of advocating for their own care.
• The informed self-advocate: Women who've done the research, know what they want to discuss (HRT, DHEA, non-hormonal options), and need a provider who won't be behind them on the science.
• The surgical menopause patient: Women who entered menopause abruptly due to oophorectomy and face an accelerated, often more intense symptom profile that general care is particularly ill-equipped to handle.
• The community seeker: Women who have clinical care but lack the social layer — who want to talk openly about libido changes, relationship dynamics, or identity shifts with people who genuinely understand.

Why Meadow Stands Out

The telehealth market is crowded, but Meadow's differentiation isn't about features — it's about focus. Vertical specificity in healthcare creates compounding advantages that general platforms can't replicate.

Specialization changes everything. Meadow providers don't need a refresher on the difference between systemic and local estrogen therapy. They don't hedge on hormone replacement out of 20-year-old fear. They understand that menopause isn't a single event but a years-long continuum, and they're equipped to support women across the full arc of it.

The Market Opportunity

Femtech has attracted significant investment attention over the past decade, but menopause-specific care remains dramatically underfunded relative to its scale. The global femtech market is projected to reach $600 billion by 2030, and menopause care is one of the fastest-growing segments within it — driven by an aging global population, rising health literacy among Gen X and millennial women, and a cultural shift in how menopause is discussed publicly.

The timing matters beyond demographics. A generation of women who demanded better care during pregnancy, who built the market for fertility tracking apps, and who destigmatized mental health conversations is now entering perimenopause. They will not accept the same dismissiveness their mothers experienced. They have the digital fluency to find better options — and the economic power to pay for them.

In the United States alone, an estimated 6,000 women enter menopause every day. The addressable market isn't a niche — it's one of the largest, most consistent patient cohorts in healthcare.

Built with AI, Built for Impact

Meadow was built using Artha — an AI-powered platform that takes a company from concept to launch-ready product with extraordinary speed. The infrastructure that powers Meadow's clinical platform, community features, and care coordination was assembled through Artha's AI-first development approach, compressing what would traditionally take months of engineering and design work into a fraction of the time.

This matters for a company like Meadow. Every week spent on infrastructure delays is a week more women spend in the cycle of inadequate care. Building on Artha meant the focus could remain where it belongs: on the clinical quality, the provider network, and the community experience — not on technical scaffolding.

The result is a platform that feels intentional, because it is. The product reflects the mission rather than being constrained by it.

What's Next for Meadow

The launch of Meadow's clinical platform is the beginning, not the destination. The roadmap reflects a company thinking about menopause care as infrastructure — something that should expand to serve women at every income level, in every geography, across every language.

Near-term, that means growing the specialist provider network, deepening the community features, and building the data layer that allows care to become more personalized over time. Longer-term, Meadow is positioned to become the definitive platform for the entire menopause continuum — from perimenopause education and early intervention, through active symptom management, into the postmenopause health landscape where cardiovascular health, bone density, and cognitive wellness require sustained clinical attention.

There's also an enterprise angle worth watching. Employers are beginning to recognize that menopause is a significant driver of productivity loss and workforce attrition among women in their 40s and 50s. A platform like Meadow, positioned as an employer benefit, could reach millions of women who would never have searched for menopause care on their own.

"We're building the menopause care infrastructure that should have existed decades ago. Not incremental improvement, but a fundamental reimagining of how women experience this chapter of their health."

That's not a modest goal. But menopause isn't a modest problem. It affects every woman. It has been neglected for generations. And the tools now exist — in clinical knowledge, in digital health infrastructure, and in AI-powered platform building — to finally do something about it.

Meadow is doing something about it. Visit meadow-care.tryartha.com to learn more.

Build Your Own Company on Artha

Meadow went from a mission statement to a full clinical platform because the technology to build fast now exists. Artha is the AI platform that turns your company idea into a real, launched product — with a website, brand, and product infrastructure ready to go from a single prompt.

If you have an idea that matters — in healthcare, in finance, in education, in any industry with a gap that's gone unaddressed for too long — Artha can help you build it. No long development cycles. No massive upfront investment. Just your idea, and the AI infrastructure to bring it to life.

Start building at artha.run →